Table 3.
In vivo gastrointestinal stability of IPY and CIY as assessed by ELISA.
| Treatments | Proventriculus | Gizzard | Proximal intestine | Distal intestine |
|---|---|---|---|---|
| IPY | 0.38 ± 0.16a | 0.55 ± 0.20a | 0.42 ± 0.09b | 0.49 ± 0.11b |
| CIY | 1.06 ± 0.76a | 0.98 ± 0.69a | 2.13 ± 0.61a | 1.53 ± 0.65a |
| P-value | 0.13 | 0.26 | 0.001 | 0.008 |
a-bMeans within a column lacking a common superscripts differ (P < 0.01).
Abbreviations: CIY, capsulated immune yolk; IPY, immune powdered yolk.
Anti-SI IgY activity in each region of the gastrointestinal tract was assessed by ELISA.
Values represent the mean ± SD, (n = 6).